JPT America, Inc.

SAN FRANCISCO, CA · CIK 0001806326 · Biotech

custom peptides, peptide microarrays, peptide pools, and peptide libraries

jpt.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$600K
1 Form D · Dec 2020
69 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$600,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2039RASHMIVU LLC——
2040Cell X Technologies, Inc.——
2041UP ONCOLYTICS, INC.——
2042JPT America, Inc.—$600K
2043ALGOMEDIX, INC.——
2044Scale-Up International Inc.—$84K
2045Tango Biosciences Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Toyohiko AyamoriDirector · Executive Officer
  • Yasuhiko HayashiDirector
  • Koji MatsunamiDirector
  • Akihiko OhashiExecutive Officer
  • Tomoaki TakashimaDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.